Highlands Oncology Group DeptofHighlandsOncologyGrp(2) — Fayetteville, Arkansas

Highlands Oncology Group DeptofHighlandsOncologyGrp(2) is a clinical research site located in Fayetteville, Arkansas, United States 72703.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group DeptofHighlandsOncologyGrp(2) has participated in 3 clinical trials.

Therapeutic areas: Breast Cancer, Advanced Gastric Cancer, Lymphoma, Mantle- Cell.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group DeptofHighlandsOncologyGrp(2)?

Highlands Oncology Group DeptofHighlandsOncologyGrp(2) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group DeptofHighlandsOncologyGrp(2) conducted?

Highlands Oncology Group DeptofHighlandsOncologyGrp(2) has 3 clinical trials on record. Their work covers Breast Cancer, Advanced Gastric Cancer, Lymphoma, Mantle- Cell.

Is Highlands Oncology Group DeptofHighlandsOncologyGrp(2) accredited by Crixeo Health?

Highlands Oncology Group DeptofHighlandsOncologyGrp(2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands Oncology Group DeptofHighlandsOncologyGrp(2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.